Related Experiment Video
Updated: Jan 21, 2026
08:42
Design and Implementation of an fMRI Study Examining Thought Suppression in Young Women with, and At-risk, for Depression
Published on: May 19, 2015
11.2K
Risk of Depressive Disorders Following Myasthenia Gravis: A Nationwide Population-Based Retrospective Cohort Study
Hsuan-Te Chu1, Chih-Chieh Tseng1, Chih-Sung Liang1,2
1Department of Psychiatry, Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Frontiers in Psychiatry
|July 30, 2019
Summary
Patients with myasthenia gravis (MG) face a significantly higher risk of developing depressive disorders. Regular assessment of depressive symptoms is crucial for individuals diagnosed with this chronic autoimmune condition.
Area of Science:
- Neurology
- Psychiatry
- Autoimmunology
Background:
- Myasthenia gravis (MG) is a chronic autoimmune disorder causing fluctuating muscle weakness and significant patient stress.
- The association between MG and mental health, particularly depressive disorders, requires further investigation.
Purpose of the Study:
- To evaluate the risk of developing depressive disorders in patients diagnosed with myasthenia gravis.
- To identify potential risk factors and comorbidities associated with depression in MG patients.
Main Methods:
- A retrospective cohort study utilizing Taiwan's National Health Insurance Research Database (NHIRD).
- Inclusion criteria: patients aged 20+ newly diagnosed with MG between 2000-2008.
- Comparison group: 1,396 controls matched for age, sex, and other factors. Follow-up until 2013.
Main Results:
- Myasthenia gravis patients exhibited a higher frequency of comorbidities, notably cerebrovascular disease.
- After adjusting for covariates, MG patients were 1.94 times more likely to develop depressive disorders (95% CI, 1.15-3.27; P=0.014).
Conclusions:
- Individuals with myasthenia gravis have an elevated risk of developing depressive disorders.
- Routine screening for depression in MG patients is recommended to ensure timely intervention and improve patient outcomes.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
01:15Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
01:27Depressive Disorders: Etiology
454
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
454
01:27Depressive Disorders: MDD and Dysthymia
715
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
715
02:04Conservation of Small Populations
16.7K
Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
16.7K
01:05Long-term Depression
33.2K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.2K